Electronic Patient-Reported Outcomes (ePROS) Market Dynamics, Recent Developments, and Strategic Insights by 2031

Electronic Patient-Reported Outcomes (ePROS) Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Delivery Mode (Cloud Based and On-Premises), Application (Oncology, Respiratory, and Others), End User [Contract Research Organizations (CROs), Pharmaceutical Companies, and Others], and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)

  • Report Code : TIPRE00039331
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 149
Buy Now

Electronic Patient-Reported Outcomes (ePROS) Market by 2031

Buy Now

The electronic patient-reported outcomes (ePROS) market size is projected to reach US$ 2,868.00 million by 2031 from US$ 843.77 million in 2023. The market is expected to register a CAGR of 16.5% during 2023–2031. The integration of artificial intelligence and machine learning with ePROS platforms is likely to act as a future trend in the market.

Electronic Patient-Reported Outcomes (ePROS) Market Analysis

The electronic patient-reported outcomes (ePROS) market is mainly driven by continuous efforts made by pharmaceutical and biotechnology sectors and medical device companies for product innovations. Other factors contributing to the market expansion include the globalization of clinical trials, rapid advancements in associated technologies, and an increase in demand for CROs for conducting clinical trials. Furthermore, conferences such as Global Clinical Trials Connect 2022 offer a platform to companies in this marketplace. The platform helps companies get acquainted with advancements in clinical trials and clinical research.

Electronic Patient-Reported Outcomes (ePROS) Market Overview

Market players are taking various strategic initiatives such as product launches, product approvals, and collaborations, which are further expected to support the market growth. For instance, in June 2024, Evidation launched MigraineSmart, which is a health engagement experience and symptom tracking program on the Evidation app that harnesses survey data, electronic patient-reported outcomes (ePROs), wearable data, and evidence-based content to make it possible for individuals to better understand and manage their migraines. Therefore, an increase in digital health technologies, a surge in demand for patient-centered care, and a rise in strategic initiatives by market players are expected to fuel the growth of the electronic patient-reported outcomes (ePROs) market in the coming years.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Electronic Patient-Reported Outcomes (ePROS) Market: Strategic Insights

electronic-patient-reported-outcomes-epros-market
Analyst Image

Mrinal

Have a question?

Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Electronic Patient-Reported Outcomes (ePROS) Market Drivers and Opportunities

Emerging Applications of Electronic Patient-Reported Outcomes (ePROS)

The emerging applications of electronic patient-reported outcomes (ePRO) drive the market. The new uses of ePRO systems in decentralized clinical trials, remote patient monitoring, and other areas are stimulating innovation and extending the use of patient-reported outcomes in various healthcare, research, and clinical settings. The adoption of ePRO systems is driven by decentralized clinical trials (DCTs) growth. Patients can participate in DCTs remotely from the comfort of their homes, and ePRO tools are widely used for collecting patient-reported data immediately. The transition to virtual trials improves patient recruitment and retention; lowers the need for in-person visits; and increases trial efficiency of various diseases, including rare diseases, across geographically dispersed populations. In addition, the players are making strategic developments to meet the customers' needs. For instance, in June 2023, uMotif, a clinical trial technology company, and Syneos Health, an integrated biopharmaceutical solution company, announced a strategic partnership. By developing a more effective, end-to-end digital platform with electronic solid clinical outcome assessment (eCOA) and electronic patient-reported outcomes (ePRO) capabilities—this partnership helped accelerate clinical trials and expedite the delivery of new therapies to patients.

ePRO systems are being used to monitor acute conditions such as post-operative recovery and chronic conditions, including diabetes and hypertension, as healthcare increasingly moves toward telemedicine and remote patient monitoring (RPM). To help healthcare providers make regular interventions and changes to care plans, patients can report symptoms, medication adherence, and treatment responses from the comfort of their own homes. This approach lowers the rate of hospital readmissions, enhances chronic illness management, and improves patient satisfaction by offering ongoing, individualized care without requiring frequent in-person visits.

The adoption of ePRO systems is propelled by the growing use of wearables, including smartwatches, fitness trackers, and Internet of Things (IoT) devices in the healthcare industry. Predictive healthcare interventions can be made possible by combining objective data from wearables with subjective patient-reported outcomes. This results in better condition monitoring and proactive condition management. Pharmaceutical companies are utilizing ePRO systems to monitor adverse events in real-world settings, helping them gain traction in pharmacovigilance and post-market surveillance, thereby ensuring long-term drug safety and efficacy while adhering to regulatory requirements.

Rising Adoption of Telehealth and Remote Monitoring to Offer Opportunity for Market Growth

The market for electronically reported patient outcomes (ePROs) is expected to experience lucrative opportunities with the rising adoption of telehealth and remote monitoring for clinical trials during the forecast period. Patients in remote or underserved areas can report real-time information from the comfort of their homes owing to telehealth and remote monitoring solutions, which increase the accessibility of patient data. Health data can be continuously transmitted via remote monitoring devices, such as wearables and linked health systems. When coupled with ePRO systems, medical professionals receive detailed information regarding a patient's condition in real time, enabling more precise and regular interventions. For example, Vivalink's integrated acute remote patient monitoring solution provides continuous and real-time monitoring of patient vitals, including live ECG, as well as information about vitals and biometrics, EPRO/ECOA/surveys, centralized data services, remote data collection, and patient adherence. The efficacy of ePRO systems is expanded by telehealth and remote monitoring developments, establishing them as a crucial element of patient-centered care.

Electronic Patient-Reported Outcomes (ePROS) Market Report Segmentation Analysis

Key segments that contributed to the derivation of the electronic patient-reported outcomes (ePROS) market analysis are delivery mode, application, and end user.

  • The electronic patient-reported outcomes (ePROS) market, based on delivery mode, is divided into cloud based and on-premise. The cloud based segment held a largest share of the market in 2023.
  • By application, the market is segmented into oncology, respiratory, and others. The oncology segment held the largest share of the market in 2023.
  • Based on end user, the electronic patient-reported outcomes (ePROS) market is segmented into CROs, pharmaceutical companies, and others. The pharmaceutical companies segment dominated the market in 2023.

Electronic Patient-Reported Outcomes (ePROS) Market Share Analysis by Geography

The geographic scope of the electronic patient-reported outcomes (ePROS) market report is mainly divided into five regions: North America, Asia Pacific, Europe, South & Central America, and the Middle East & Africa. In terms of revenue, North America dominated the market in 2023. The market in this region is mainly driven by the presence of developed healthcare infrastructure, increased focus on digital health, and rise in product launches and other strategic initiatives by market players. The US is the largest and fastest-growing market for electronic patient-reported outcomes (ePROS). The country accounts for the major market share owing to the increasing use of digital health technologies, which helps provide patient-centered care. This involves integrating healthcare services with software and hardware, which can be managed and monitored with the help of apps, wearable devices, and other devices. The increasing focus on chronic disease management has increased the demand for ePROs as they allow continuous assessment and timely interventions. As per the article published by the American Society of Clinical Oncology in June 2023, in the US, ePRO inclusion in the Centers for Medicare and Medicaid Innovation's alternative payment model pilot, the Enhancing Oncology Model, is a sign that ePRO implementation should be a crucial step toward high-quality and transformational cancer care that is likely to foster broader adoption. The surging number of clinical trials in the country is expected to increase the demand for ePROs during the forecast period.

Electronic Patient-Reported Outcomes (ePROS) Market Report Scope

Electronic Patient-Reported Outcomes (ePROS) Market News and Recent Developments

The electronic patient-reported outcomes (ePROS) market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the market are listed below:

  • Clinical Ink launched EDCXtra—an innovative Electronic Data Capture (EDC) system. EDCXtra incorporates all existing DDC functionality into a single web-based application, which includes Clinical ink’s industry-leading electronic Clinical Outcome Assessments (eCOAs) and eConsent solutions. This application provides a comprehensive, all-in-one GCP-compliant platform. (Source: Clinical Ink, Company Website, August 2024)
  • PatientIQ launched ResearchPRO an electronic data capture (EDC) platform designed to streamline the process of launching and managing research studies. With the introduction of ResearchPRO, PatientIQ is able to provide a more dedicated and sophisticated solution set tailored specifically to the unique needs of clinical researchers, clinical research organizations (CROs), and industry sponsors. (Source: PatientIQ, Company Website, July 2024)

Electronic Patient-Reported Outcomes (ePROS) Market Report Coverage and Deliverables

The "Electronic Patient-Reported Outcomes (ePROS) Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:

  • Electronic patient-reported outcomes (ePROS) market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Electronic patient-reported outcomes (ePROS) market trends, as well as market dynamics such as drivers, restraints, and key opportunities
  • Detailed PEST and SWOT analysis
  • Electronic patient-reported outcomes (ePROS) market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
  • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the electronic patient-reported outcomes (ePROS) market
  • Detailed company profiles
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which are the leading players operating in the electronic patient-reported outcomes (ePROS) market?

OpenClinica LLC, Buddy Healthcare Ltd Oy, Castor, Medable Inc, Assistek, Signant Health, Crucial Data Solutions, Curebase, Y-Prime LLC, Clinical Ink Inc, Medidata Solutions, Veeva Systems Inc, Medrio, and PatientIQ are among the key players in the market.

What are the driving factors impacting the electronic patient-reported outcomes (ePROS) market?

The emerging applications of electronic patient-reported outcomes (ePROS) and increasing focus on patient-centered care activities are among the most significant factors fueling the market growth.

What would be the estimated value of the electronic patient-reported outcomes (ePROS) market by 2031?

The electronic patient-reported outcomes (ePROS) market value is expected to reach US$ 2,868.00 million by 2031.

What is the expected CAGR of the electronic patient-reported outcomes (ePROS) market?

The market is expected to register a CAGR of 16.5% during 2023–2031.

What are the future trends of the electronic patient-reported outcomes (ePROS) market?

Integration of artificial intelligence and machine learning with ePROS platforms is expected to be a prime trend in the market in the coming years.

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:

3.2.2 Macro-economic factor analysis:

3.2.3 Developing base number:

3.2.4 Data Triangulation:

3.2.5 Country level data:

4. Electronic Patient-Reported Outcomes (ePROS) Market Landscape

4.1 Overview

4.2 PEST Analysis

4.3 Benefits of ePROs

4.4 Use of ePRO in Clinical Trials

4.5 List of Hospitals Using ePRO in each country

5. Electronic Patient-Reported Outcomes (ePROS) Market – Key Market Dynamics

5.1 Electronic Patient-Reported Outcomes (ePROS) Market – Key Market Dynamics

5.2 Market Drivers:

5.2.1 Emerging Applications of Electronic Patient-Reported Outcomes (ePROS)

5.2.2 Increasing Focus on Patient-Centered Care

5.3 Market Restraints

5.3.1 Data Privacy and Security Issues

5.4 Market Opportunities

5.4.1 Rising Adoption of Telehealth and Remote Monitoring

5.5 Future Trends

5.5.1 Integration of Artificial Intelligence and Machine Learning with ePROS Platforms

5.6 Impact of Drivers and Restraints:

6. Electronic Patient-Reported Outcomes (ePROS) Market – Global Market Analysis

6.1 Electronic Patient-Reported Outcomes (ePROS) Market Revenue (US$ Million), 2021–2031

6.2 Electronic Patient-Reported Outcomes (ePROS) Market Forecast Analysis

7. Electronic Patient-Reported Outcomes (ePROS) Market Analysis – by Delivery Mode

7.1 Cloud Based

7.1.1 Overview

7.1.2 Cloud Based: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million)

7.2 On-Premise

7.2.1 Overview

7.2.2 On-Premise: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million)

8. Electronic Patient-Reported Outcomes (ePROS) Market Analysis – by Application

8.1 Oncology

8.1.1 Overview

8.1.2 Oncology: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million)

8.2 Respiratory

8.2.1 Overview

8.2.2 Respiratory: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million)

8.3 Others

8.3.1 Overview

8.3.2 Others: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million)

9. Electronic Patient-Reported Outcomes (ePROS) Market Analysis – by End User

9.1 CROs

9.1.1 Overview

9.1.2 CROs: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million)

9.2 Pharmaceutical Companies

9.2.1 Overview

9.2.2 Pharmaceutical Companies: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million)

9.3 Others

9.3.1 Overview

9.3.2 Others: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million)

10. Electronic Patient-Reported Outcomes (ePROS) Market – Geographical Analysis

10.1 Overview

10.2 North America

10.2.1 North America Electronic Patient-Reported Outcomes (ePROS) Market Overview

10.2.2 North America: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million)

10.2.3 North America: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast Analysis – by Delivery Mode

10.2.4 North America: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast Analysis – by Application

10.2.5 North America: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast Analysis – by End User

10.2.6 North America: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast Analysis – by Country

10.2.6.1 United States: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million)

10.2.6.1.1 United States: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode

10.2.6.1.2 United States: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application

10.2.6.1.3 United States: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User

10.2.6.2 Canada: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million)

10.2.6.2.1 Canada: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode

10.2.6.2.2 Canada: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application

10.2.6.2.3 Canada: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User

10.2.6.3 Mexico: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million)

10.2.6.3.1 Mexico: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode

10.2.6.3.2 Mexico: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application

10.2.6.3.3 Mexico: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User

10.3 Europe

10.3.1 Europe Electronic Patient-Reported Outcomes (ePROS) Market Overview

10.3.2 Europe: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million)

10.3.3 Europe: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast Analysis – by Delivery Mode

10.3.4 Europe: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast Analysis – by Application

10.3.5 Europe: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast Analysis – by End User

10.3.6 Europe: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast Analysis – by Country

10.3.6.1 United Kingdom: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million)

10.3.6.1.1 United Kingdom: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode

10.3.6.1.2 United Kingdom: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application

10.3.6.1.3 United Kingdom: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User

10.3.6.2 Germany: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million)

10.3.6.2.1 Germany: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode

10.3.6.2.2 Germany: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application

10.3.6.2.3 Germany: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User

10.3.6.3 France: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million)

10.3.6.3.1 France: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode

10.3.6.3.2 France: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application

10.3.6.3.3 France: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User

10.3.6.4 Italy: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million)

10.3.6.4.1 Italy: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode

10.3.6.4.2 Italy: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application

10.3.6.4.3 Italy: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User

10.3.6.5 Spain: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million)

10.3.6.5.1 Spain: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode

10.3.6.5.2 Spain: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application

10.3.6.5.3 Spain: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User

10.3.6.6 Rest of Europe: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million)

10.3.6.6.1 Rest of Europe: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode

10.3.6.6.2 Rest of Europe: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application

10.3.6.6.3 Rest of Europe: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User

10.4 Asia Pacific

10.4.1 Asia Pacific Electronic Patient-Reported Outcomes (ePROS) Market Overview

10.4.2 Asia Pacific: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million)

10.4.3 Asia Pacific: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast Analysis – by Delivery Mode

10.4.4 Asia Pacific: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast Analysis – by Application

10.4.5 Asia Pacific: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast Analysis – by End User

10.4.6 Asia Pacific: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast Analysis – by Country

10.4.6.1 Japan: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million)

10.4.6.1.1 Japan: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode

10.4.6.1.2 Japan: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application

10.4.6.1.3 Japan: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User

10.4.6.2 China: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million)

10.4.6.2.1 China: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode

10.4.6.2.2 China: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application

10.4.6.2.3 China: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User

10.4.6.3 India: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million)

10.4.6.3.1 India: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode

10.4.6.3.2 India: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application

10.4.6.3.3 India: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User

10.4.6.4 South Korea: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million)

10.4.6.4.1 South Korea: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode

10.4.6.4.2 South Korea: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application

10.4.6.4.3 South Korea: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User

10.4.6.5 Australia: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million)

10.4.6.5.1 Australia: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode

10.4.6.5.2 Australia: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application

10.4.6.5.3 Australia: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User

10.4.6.6 Rest of APAC: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million)

10.4.6.6.1 Rest of APAC: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode

10.4.6.6.2 Rest of APAC: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application

10.4.6.6.3 Rest of APAC: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User

10.5 South & Central America

10.5.1 South & Central America Electronic Patient-Reported Outcomes (ePROS) Market Overview

10.5.2 South & Central America: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million)

10.5.3 South & Central America: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast Analysis – by Delivery Mode

10.5.4 South & Central America: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast Analysis – by Application

10.5.5 South & Central America: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast Analysis – by End User

10.5.6 South & Central America: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast Analysis – by Country

10.5.6.1 Brazil: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million)

10.5.6.1.1 Brazil: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode

10.5.6.1.2 Brazil: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application

10.5.6.1.3 Brazil: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User

10.5.6.2 Argentina: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million)

10.5.6.2.1 Argentina: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode

10.5.6.2.2 Argentina: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application

10.5.6.2.3 Argentina: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User

10.5.6.3 Rest of South & Central America: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million)

10.5.6.3.1 Rest of South & Central America: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode

10.5.6.3.2 Rest of South & Central America: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application

10.5.6.3.3 Rest of South & Central America: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User

10.6 Middle East & Africa

10.6.1 Middle East & Africa Electronic Patient-Reported Outcomes (ePROS) Market Overview

10.6.2 Middle East & Africa: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million)

10.6.3 Middle East & Africa: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast Analysis – by Delivery Mode

10.6.4 Middle East & Africa: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast Analysis – by Application

10.6.5 Middle East & Africa: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast Analysis – by End User

10.6.6 Middle East & Africa: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast Analysis – by Country

10.6.6.1 Saudi Arabia: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million)

10.6.6.1.1 Saudi Arabia: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode

10.6.6.1.2 Saudi Arabia: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application

10.6.6.1.3 Saudi Arabia: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User

10.6.6.2 South Africa: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million)

10.6.6.2.1 South Africa: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode

10.6.6.2.2 South Africa: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application

10.6.6.2.3 South Africa: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User

10.6.6.3 United Arab Emirates: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million)

10.6.6.3.1 United Arab Emirates: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode

10.6.6.3.2 United Arab Emirates: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application

10.6.6.3.3 United Arab Emirates: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User

10.6.6.4 Rest of Middle East & Africa: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million)

10.6.6.4.1 Rest of Middle East & Africa: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Delivery Mode

10.6.6.4.2 Rest of Middle East & Africa: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Application

10.6.6.4.3 Rest of Middle East & Africa: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by End User

11. Electronic Patient-Reported Outcomes (ePROS) Market – Industry Landscape

11.1 Overview

11.2 Growth Strategies in Electronic Patient-Reported Outcomes (ePROS) Market

11.3 Organic Growth Strategies

11.3.1 Overview

11.4 Inorganic Growth Strategies

11.4.1 Overview

12. Company Profiles

12.1 OpenClinica LLC

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Buddy Healthcare Ltd Oy

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Castor

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Medable Inc

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Assistek

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Signant Health

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Crucial Data Solutions

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 Curebase

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 Y-Prime LLC

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 Clinical Ink Inc

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Products and Services

12.10.4 Financial Overview

12.10.5 SWOT Analysis

12.10.6 Key Developments

12.11 Medidata Solutions

12.11.1 Key Facts

12.11.2 Business Description

12.11.3 Products and Services

12.11.4 Financial Overview

12.11.5 SWOT Analysis

12.11.6 Key Developments

12.12 Veeva Systems Inc

12.12.1 Key Facts

12.12.2 Business Description

12.12.3 Products and Services

12.12.4 Financial Overview

12.12.5 SWOT Analysis

12.12.6 Key Developments

12.13 Medrio

12.13.1 Key Facts

12.13.2 Business Description

12.13.3 Products and Services

12.13.4 Financial Overview

12.13.5 SWOT Analysis

12.13.6 Key Developments

12.14 PatientIQ

12.14.1 Key Facts

12.14.2 Business Description

12.14.3 Products and Services

12.14.4 Financial Overview

12.14.5 SWOT Analysis

12.14.6 Key Developments

13. Appendix

13.1 About Us

13.2 Glossary of Terms

List of Tables

Table 1. Electronic Patient-Reported Outcomes (ePROS) Market Segmentation

Table 2. Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million) – by Delivery Mode

Table 3. Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million) – by Application

Table 4. Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million) – by End User

Table 5. North America: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by Delivery Mode

Table 6. North America: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 7. North America: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 8. United States: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by Delivery Mode

Table 9. United States: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 10. United States: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 11. Canada: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by Delivery Mode

Table 12. Canada: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 13. Canada: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 14. Mexico: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by Delivery Mode

Table 15. Mexico: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 16. Mexico: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 17. Europe: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by Delivery Mode

Table 18. Europe: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 19. Europe: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 20. United Kingdom: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by Delivery Mode

Table 21. United Kingdom: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 22. United Kingdom: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 23. Germany: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by Delivery Mode

Table 24. Germany: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 25. Germany: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 26. France: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by Delivery Mode

Table 27. France: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 28. France: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 29. Italy: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by Delivery Mode

Table 30. Italy: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 31. Italy: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 32. Spain: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by Delivery Mode

Table 33. Spain: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 34. Spain: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 35. Rest of Europe: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by Delivery Mode

Table 36. Rest of Europe: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 37. Rest of Europe: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 38. Asia Pacific: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by Delivery Mode

Table 39. Asia Pacific: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 40. Asia Pacific: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 41. Japan: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by Delivery Mode

Table 42. Japan: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 43. Japan: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 44. China: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by Delivery Mode

Table 45. China: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 46. China: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 47. India: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by Delivery Mode

Table 48. India: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 49. India: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 50. South Korea: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by Delivery Mode

Table 51. South Korea: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 52. South Korea: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 53. Australia: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by Delivery Mode

Table 54. Australia: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 55. Australia: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 56. Rest of APAC: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by Delivery Mode

Table 57. Rest of APAC: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 58. Rest of APAC: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 59. South & Central America: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by Delivery Mode

Table 60. South & Central America: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 61. South & Central America: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 62. Brazil: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by Delivery Mode

Table 63. Brazil: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 64. Brazil: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 65. Argentina: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by Delivery Mode

Table 66. Argentina: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 67. Argentina: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 68. Rest of South & Central America: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by Delivery Mode

Table 69. Rest of South & Central America: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 70. Rest of South & Central America: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 71. Middle East & Africa: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by Delivery Mode

Table 72. Middle East & Africa: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 73. Middle East & Africa: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 74. Saudi Arabia: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by Delivery Mode

Table 75. Saudi Arabia: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 76. Saudi Arabia: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 77. South Africa: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by Delivery Mode

Table 78. South Africa: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 79. South Africa: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 80. United Arab Emirates: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by Delivery Mode

Table 81. United Arab Emirates: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 82. United Arab Emirates: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 83. Rest of Middle East & Africa: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by Delivery Mode

Table 84. Rest of Middle East & Africa: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 85. Rest of Middle East & Africa: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 86. Recent Organic Growth Strategies in Electronic Patient-Reported Outcomes (ePROS) Market

Table 87. Recent Inorganic Growth Strategies in the Electronic Patient-Reported Outcomes (ePROS) Market

Table 88. Glossary of Terms, Electronic Patient-Related Outcomes (ePROS) Market

List of Figures

Figure 1. Electronic Patient-Reported Outcomes (ePROS) Market Segmentation, by Geography

Figure 2. PEST Analysis

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. Electronic Patient-Reported Outcomes (ePROS) Market Revenue (US$ Million), 2021–2031

Figure 5. Electronic Patient-Reported Outcomes (ePROS) Market Share (%) – by Delivery Mode (2023 and 2031)

Figure 6. Cloud Based: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million)

Figure 7. On-Premise: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million)

Figure 8. Electronic Patient-Reported Outcomes (ePROS) Market Share (%) – by Application (2023 and 2031)

Figure 9. Oncology: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million)

Figure 10. Respiratory: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million)

Figure 11. Others: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million)

Figure 12. Electronic Patient-Reported Outcomes (ePROS) Market Share (%) – by End User (2023 and 2031)

Figure 13. CROs: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million)

Figure 14. Pharmaceutical Companies: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million)

Figure 15. Others: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031 (US$ Million)

Figure 16. Electronic Patient-Reported Outcomes (ePROS) Market Breakdown by Region, 2023 and 2031 (%)

Figure 17. North America: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million)

Figure 18. North America: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Key Countries, 2023 and 2031 (%)

Figure 19. United States: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million)

Figure 20. Canada: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million)

Figure 21. Mexico: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million)

Figure 22. Europe: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million)

Figure 23. Europe: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Key Countries, 2023 and 2031 (%)

Figure 24. United Kingdom: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million)

Figure 25. Germany: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million)

Figure 26. France: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million)

Figure 27. Italy: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million)

Figure 28. Spain: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million)

Figure 29. Rest of Europe: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million)

Figure 30. Asia Pacific: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million)

Figure 31. Asia Pacific: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Key Countries, 2023 and 2031 (%)

Figure 32. Japan: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million)

Figure 33. China: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million)

Figure 34. India: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million)

Figure 35. South Korea: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million)

Figure 36. Australia: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million)

Figure 37. Rest of APAC: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million)

Figure 38. South & Central America: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million)

Figure 39. South & Central America: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Key Countries, 2023 and 2031 (%)

Figure 40. Brazil: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million)

Figure 41. Argentina: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million)

Figure 42. Rest of South & Central America: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million)

Figure 43. Middle East & Africa: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million)

Figure 44. Middle East & Africa: Electronic Patient-Reported Outcomes (ePROS) Market Breakdown, by Key Countries, 2023 and 2031 (%)

Figure 45. Saudi Arabia: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million)

Figure 46. South Africa: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million)

Figure 47. United Arab Emirates: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million)

Figure 48. Rest of Middle East & Africa: Electronic Patient-Reported Outcomes (ePROS) Market – Revenue and Forecast to 2031(US$ Million)

Figure 49. Growth Strategies in Electronic Patient-Reported Outcomes (ePROS) Market

The List of Companies - Electronic Patient-Reported Outcomes (ePROS) Market

  • OpenClinica LLC
  • Buddy Healthcare Ltd Oy
  • Castor
  • Medable Inc
  • Assistek
  • Signant Health
  • Crucial Data Solutions
  • Curebase
  • Y-Prime LLC
  • Clinical Ink Inc

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Life Sciences : READ MORE..